LILLY ELI & CO (LLY)
Price: $37.68
Industry: Drugs Chaikin Power Gauge Report | Generated: Thu Jun 23 13:39 EDT 2011 LLY LILLY ELI & CO
$37.68
Power Gauge Rating
LLY - Very Bullish TM
The Chaikin Power Gauge Rating for LLY is very bullish due to very attractive financial metrics, very positive expert opinions and bullish price/volume activity. The rating also reflects weak earnings performance.
Financial Metrics
LLY's financial metrics are excellent due to a high return on equity and low price to sales ratio.
Earnings Performance
Price/Volume Activity
Expert Opinions
News Sentiment Rating
Neutral LLY LILLY ELI & CO
June 22, 2011
TM
Chaikin Sentiment Gauge for LLY is neutral. Stories concerning LLY have a balanced or neutral sentiment.
News Sentiment :Neutral
Power Trend - 5 Year Chart
The Power Gauge distills a 20 factor model into a concise picture of a stock's potential.
I want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here
High Potential
Neutral
Low Potential
www.chaikinpowertools.com
Financials & Earnings
Financial Metrics
Financial Metrics Rating
Very Bullish
LT Debt/Equity Ratio
LLY's financial metrics are excellent. The company yields a high return on shareholder's equity and has high revenue per share.
Price to Book Value
The rank is based on a high long term debt to equity ratio, high price to book value ratio, high return on equity, low price to sales ratio and relatively high cash flow.
Return on Equity
Price to Sales Ratio
Business Value
Assets and Liabilities
Valuation
Returns
Ratio
TTM
Ratio
TTM
Ratio
Current Ratio
2.01
Price/Book
3.13
Return on Invest
28.5%
LT Debt/Equity
0.55
Price/Sales
1.89
Return on Equity
43.4%
Earnings Performance
TTM
Earnings Performance Rating
Bearish
Earnings Growth
LLY's earnings performance has been weak. The company is priced relatively high compared to next year's projected EPS and has an erratic 5 year earnings trend.
Earnings Surprise
Earnings Trend
The rank is based on high earnings growth over the past 3-5 years, a relatively high projected P/E ratio and inconsistent earnings over the past 5 years.
Projected P/E Ratio
Earnings Consistency
5 Year Revenue and Earnings Growth
Revenue(M) Rev % Growth EPS EPS % Growth
EPS Estimates
12/06
12/07
12/08
12/09
12/10
15,691.00
18,633.50
20,378.00
21,836.00
23,076.00
7.14%
18.75%
9.36%
7.15%
5.68%
$2.45
$2.71
$-1.89
$3.94
$4.58
34.62%
10.61%
-169.74%
308.47%
16.24%
EPS Surprise
Factor
Actual EPS Prev
EST EPS Current
Change
$1.22
$1.17
-0.05
Quarterly EPS Yearly EPS Factor
$4.58
$4.27
-0.31
Actual EPS Growth
Est EPS Growth
Change
9.62%
-4.38%
-14.00
3-5 year EPS
EPS Quarterly Results Estimate
Actual
Difference
% Difference
FY
Qtr 1
Qtr 2
Qtr 3
Qtr 4
Total
Latest Qtr
$1.17
$1.24
$0.07
1 Qtr Ago
$1.10
$1.11
$0.01
5.98
12/09
$1.20
$1.06
$0.86
$0.83
$3.95
0.91
12/10
$1.13
$1.22
$1.18
$1.05
$4.58
2 Qtr Ago
$1.15
$1.21
3 Qtr Ago
$1.11
$1.24
$0.06
5.22
12/11
$0.95
-
-
-
-
$0.13
11.71
Fiscal Year End Month is December.
I want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here
www.chaikinpowertools.com
Price Trend & Expert Opinions Price/Volume Activity
Price/Volume Activity Rating
Bullish
Relative Strength vs Market
Chaikin Money Flow
Price and volume activity for LLY is bullish. LLY has outperformed the S&P 500 over 26 weeks and has a rising price trend.
Price Trend
The rank for LLY is based on its price strength versus the market, a positive Chaikin price trend and a negative Chaikin price trend ROC.
Price Trend ROC
Volume Trend
Relative Strength vs S&P500 Index
Chaikin Money Flow
Chart shows whether LLY is performing better or worse than the market.
Chaikin Money Flow analyzes supply and demand for a company's stock.
Price Activity
Price Activity
Volume Activity
Factor
Value
Factor
52 Week High
39.15
% Change Price - 4 Weeks
-1.64%
Average Volume 20 Days
6,527,498
52 Week Low
33.12
% Change Price - 24 Weeks
8.34%
Average Volume 90 Days
7,134,977
% Change Price - 4 Wks Rel to S&P
0.90%
Chaikin Money Flow Persistency
% Change Price - 24 Wks Rel to S&P
7.45%
% Change YTD Rel S&P 500
5.37%
Expert Opinions
Value
Factor
Value
58%
Expert Opinions
Very Bullish
Earnings Estimate Revisions
Expert opinions about LLY are very positive. Insiders are net buyers of LLY's stock and analysts's opinions on LLY have been more positive recently.
Short Interest
Insider Activity
The rank for LLY is based on analysts revising earnings estimates upward, a low short interest ratio, insiders purchasing stock, optimistic analyst opinions and price strength of the stock versus the Drugs industry group.
Analyst Opinions
Relative Strength vs Industry
Earnings Estimate Revisions Current Current Qtr Next Qtr
1.17 1.08 Current
Current FY
4.27
Analyst Recommendations
7 Days Ago % Change 1.17 1.08
0.00% 0.00%
30 Days Ago % Change 4.27
0.00
Factor Mean this Week Mean Last Week
EPS Estimates Revision Summary Value
Hold 0.00
Mean 5 Weeks Ago
Hold
Last 4 Weeks
Down
Up
Down
Curr Qtr
0
0
0
0
Curr Yr
0
0
1
0
Next Qtr
0
0
0
0
Next Yr
0
0
1
1
Hold
Change
I want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here
Last Week Up
www.chaikinpowertools.com
The Company & Its Competitors
News Headlines for LLY
LLY's Competitors in Drugs Company
Power Gauge
Historic EPS growth
Projected EPS growth
Profit Margin
PEG
PE
Revenue(M)
LLY
9.62%
-4.38%
20.82%
-2.02
7.85
23,076
MRK
18.19%
3.34%
3.48%
2.87
10.10
45,987
JNJ
4.21%
6.03%
19.77%
2.22
13.71
61,587
NVS
9.55%
4.92%
18.64%
2.25
11.84
50,624
PFE
6.66%
3.06%
12.51%
2.97
9.09
67,809
GSK
3.26%
4.10%
6.89%
2.70
14.24
45,905
EU approves Lilly's weekly diabetes drug Bydureon - Jun 21, 2011 Lilly for Better Healthâ„¢ Launches Enhanced Multi-Channel Patient Education Platform - Jun 14, 2011 Judge orders drug company to pay SC $327 million - Jun 3, 2011 Peregrine Appoints Jeffrey Masten as Vice President - May 31, 2011 Lilly USA, LLC Launches TruAssist for Patients May 16, 2011
Company Details
Company Profile
LILLY ELI & CO LILLY CORPORATE CTR INDIANAPOLIS, IN 46285 USA Phone: 3172762000 Fax: 317-276-4878 Website: http://http://www.lilly.com Full Time Employees: 38,350 Sector: Medical
Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.
Power Gauge Ratings are created using a relative ranking system that assigns a rank of 0 to 100 (100 being the highest) to each stock in the universe. Rank is calculated by evaluating each of the stocks factors and combining them into a single number using a weighting formula. A stock's rank ranges from 100-0, where 100 is the strongest, and a rank of 95 indicates the stock is better than 95% of the stocks in the universe. Chaikin Stock Research(CSR) is not registered as a securities broker dealer or investment advisor with either the U.S. Securities and Exchange Commission or with any state securities regulatory authority. CSR is not responsible for trades executed by users of this research report, our web site or mobile app based on the information included herein. The information presented in this report does not represent a recommendation to buy or sell stocks or any financial instrument nor is it intended as an endorsement of any security or investment. The information in this report is generic by nature and is not personalized to the specific financial situation of any individual. The user bears complete responsibility for their own investment research and should seek the advice of a qualified investment professional before making any investment decisions. Copyright (c) 1978-(Present) by ZACKS Investment Research, Inc ("ZACKS"). The information, data, analyses and opinions contained herein (1) includes the confidential and proprietary information of ZACKS, (2) may not be copied or redistributed, for any purpose, (3) does not constitute investment advice offered by ZACKS, (4) are provided solely for informational purposes, and (5) are not warranted or represented to be correct, complete, accurate or timely. ZACKS shall not be responsible for investment decisions, damages or other losses resulting from, or related to, use of this information, data, analyses or opinions. Past performance is no guarantee of future performance. ZACKS is not affiliated with Chaikin Power Tools. This report from Chaikin Power Tools is for informational purposes only and is not a recommendation to buy or sell securities.
LM 2.3 DS 3.0 LS 2.1
Data Provided by ZACKS Investment Research, Inc., www.zacks.com
Special offers to trade stocks from optionsXpress: www.chaikinpowertools.com